Medical stocks not affected by large purchases
Medical stocks not affected by large purchases, which requires access to relevant information in order to answer the answer, according to years of learning experience, if the answer is not affected by a large number of purchases of medical stocks, can make you twice as easy as twice the effort, the following share not affected by a large number of purchases of medical stocks related to the methodology of the experience, for you to refer to the reference.
Medical Stocks Not Affected by Bulk Purchasing
Medical stocks generally refer to healthcare service stocks, which are companies that provide services to healthcare organizations and derive revenues from them, including medical devices, pharmaceuticals, healthcare information technology, healthcare logistics, and medical auxiliary companies. These companies are not related to mass purchases and therefore are not affected by mass purchases.
The following are some of the medical stocks that are not affected by mass purchasing:
__Myriad Medical: Domestic medical device leader, with products covering life information and support, in-vitro diagnostics, medical imaging and other fields.
__ Jianfan Bio: domestic blood purification field leader, products covering blood perfusion, hemodialysis, blood filtration and other products.
__Nanwei Medicine: a leading enterprise in the field of gastrointestinal endoscopic diagnostic and therapeutic instruments in China, with products covering gastrointestinal endoscopic diagnostic and therapeutic instruments, anastomoses and other products.
__Contact Medical: a leading domestic high-end medical device company, with products covering anesthesia systems, respiratory machines, electrocardiographs and other high-end medical devices.
__Yuyue Medical: a leading domestic household medical equipment company, with products covering blood pressure monitors, stethoscopes, nebulizers and other household medical equipment.
__ Wanbangde: a leading domestic chemical drug company in the field of cardiovascular and cerebrovascular drugs, with products covering anti-hypertensives, anti-angina, anti-thrombotic drugs and other products.
It should be noted that the above are only some of the medical stocks that are not affected by the massive procurement, investment risk, investors should choose according to their own risk appetite and investment objectives.
Medical and pharmaceutical stocks not affected by mass purchasing
Medical and pharmaceutical stocks not affected by mass purchasing are more, the following is a list of a few:
___Vantage Biologics: Its bivalent HPV vaccine is the only vaccine that reduces the risk of cervical cancer through vaccination by blocking HPV16/18 infections, and it has been signed a long-term supply agreement for 50 million doses.
___Tiger Pharmaceuticals: The Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) are essential qualifications for pharmaceutical research and development. Tigermed is one of the companies in the industry with these two qualifications, and has these two "dual-qualification" certifications.
The above are just some examples, medical and pharmaceutical stocks are affected by the collection, but also according to the specific circumstances of the company to judge.
Not affected by the collection of medical stocks which
Medical stocks, the following companies may not be affected by the collection:
___Guoshengtang: the company's Chinese medicine designated retail pharmacy number of 140, and all of them are the controlling subsidiary. This enables Gushengtang to circumvent the centralized procurement policy of large medical equipment for urban public hospitals negotiated by the National Health Insurance Bureau.
__ Jianhui Information: The company mainly provides intelligent medical logistics services for hospitals, which is not part of the national centralized procurement.
__Xinlitai: The company mainly produces drugs and develops new indications to meet clinical needs. In addition, Xinlitai's medicines do not rely on centralized procurement.
This information is for reference only. Investment involves risks and decisions should be made with caution. Investors should make independent decisions based on their own circumstances.
List of Medical Stocks Not Affected by Collective Purchasing
Among the medical stocks not affected by collective purchasing, the following stocks may be of investment value:
___Warwick Genetics: Its holding company, Warwick Medical, has a 51 percent stake in Firestone Recreation Technology (Beijing) Co. The company has two major industries, super equipment and intelligent health care, and also laid out the "regional intelligent medical association + reproductive medicine center" double track, the business scope covers reproductive medicine, intelligent health care and other fields.
__AntuBio: The company specializes in in vitro diagnostics, with products covering infectious diseases, liver function, kidney function, clinical chemistry, clinical testing and other categories, which can meet the diversified needs of diagnostic reagents and instruments in hospitals, and is not directly linked to the collective procurement policy.
___Auhua Endoscopy: Although there is no endoscope for the digestive tract in its product line, the company's endoscopy product line has a complete layout, and there are layouts in the fields of urology, respiration, digestion, and so on.
In addition, Myriad Medical, Mindray Bio, Kaili Medical, Aier Ophthalmology, and Tongze Medical are also often regarded by investors as medical stocks that are not affected by centralized procurement. These companies have relatively high business independence and performance stability, and often win bids in centralized procurement by public hospitals.
Please note that investment in the healthcare sector carries risks, so be sure to conduct thorough research and analysis before investing.
Medical stocks not affected by centralized purchasing
The medical industry is closely related to the centralized purchasing policy, and the following are some of the medical stocks that are not affected by centralized purchasing or less affected by centralized purchasing:
__Guoshengtang: The company is a medical institution focusing on Chinese medicine healthcare services, which is rich in Chinese medicine resources and professional medical service that is not affected by the collective purchasing policy.
__ Jianhui Information: The company is a medical information technology solutions company, the main business includes hospital information technology, clinical medical information technology and primary medical information technology, and has little to do with the procurement policy.
__Weining Health: the company is a company focusing on healthcare informatization, and its main business includes hospital informatization, clinical healthcare informatization and primary healthcare informatization, which has little to do with the collection and procurement policy.
The above are some of the medical stocks that are not affected by the collection or less affected by the collection, but please pay attention to the investment risk and conduct sufficient research and analysis.
That's it for the introduction of healthcare stocks not affected by bulk purchasing.